Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Ontrak, Inc.
  6. News
  7. Summary
    OTRK   US6833731044

ONTRAK, INC.

(OTRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ontrak : Cannacord Upgrades Ontrak to Buy Rating From Hold, Adjusts Price Target to $46 From $32

03/16/2021 | 11:27am EDT


© MT Newswires 2021
All news about ONTRAK, INC.
05/06ONTRAK  : Earnings Flash (OTRK) ONTRAK Posts Q1 Revenue $28.7M, vs. Street Est o..
MT
05/06ONTRAK  : Earnings Flash (OTRK) ONTRAK Reports Q1 Loss $-0.17, vs. Street Est of..
MT
05/06ONTRAK, INC.  : Results of Operations and Financial Condition, Financial Stateme..
AQ
05/06ONTRAK  : Announces 2021 First Quarter Financial Results
BU
05/06ONTRAK  : Management's Discussion and Analysis of Financial Condition and Result..
AQ
05/05ONTRAK  : Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferre..
BU
05/04ONTRAK  : Landmark Behavioral Health Treatment Effect Study Shows 64% Reduction ..
BU
05/01FINAL DEADLINE ALERT : ROSEN, A LEADING LAW FIRM, Encourages Ontrak, Inc. Invest..
BU
04/30OTRK DEADLINE ALERT : Bronstein, Gewirtz & Grossman, LLC Reminds Ontrak, Inc. In..
BU
04/29THE LAW OFFICES OF FRANK R. CRUZ  : Reminds Investors of Looming Deadline in the..
BU
More news
Financials (USD)
Sales 2021 97,3 M - -
Net income 2021 -31,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -17,0x
Yield 2021 -
Capitalization 507 M 507 M -
Capi. / Sales 2021 5,21x
Capi. / Sales 2022 3,24x
Nbr of Employees 724
Free-Float 41,8%
Chart ONTRAK, INC.
Duration : Period :
Ontrak, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONTRAK, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 46,00 $
Last Close Price 28,65 $
Spread / Highest target 155%
Spread / Average Target 60,6%
Spread / Lowest Target 11,7%
EPS Revisions
Managers and Directors
NameTitle
Jonathan E. Mayhew Chief Executive Officer
Curt Medeiros President & Chief Operating Officer
Brandon H. LaVerne Chief Financial Officer
Terren S. Peizer Executive Chairman
Julia Wright Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ONTRAK, INC.-53.63%507
CVS HEALTH CORPORATION22.55%109 328
HCA HEALTHCARE, INC.27.28%68 723
LABORATORY CORPORATION OF AMERICA HOLDINGS35.70%26 986
REDE D'OR SÃO LUIZ S.A.1.90%25 121
FRESENIUS MEDICAL CARE AG & CO. KGAA-5.89%23 228